Iron Supplementation and Omega-3 Fatty Acids in Tuberculosis: Friend or Foe?

Area of Science:

• Nutritional Immunology
• Infectious Diseases

Background:

• Iron supplementation in tuberculosis is debated due to iron's role in host immunity and Mycobacterium tuberculosis pathogenesis.
• Long-chain omega-3 polyunsaturated fatty acids (PUFAs), specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are being investigated for their immunomodulatory effects in tuberculosis.

Purpose of the Study:

• To review the roles of iron metabolism and omega-3 fatty acids in tuberculosis.
• To emphasize their impact on inflammation, immune responses, anemia, and nutritional support.
• To highlight the need for individualized nutritional strategies and further research.

Main Methods:

• Literature review focusing on iron and omega-3 fatty acids in tuberculosis.
• Analysis of existing experimental and limited human clinical evidence.
• Discussion of factors influencing efficacy and safety, including disease activity and nutrient interactions.

Main Results:

• Iron supplementation's routine use is not supported; efficacy depends on inflammation, iron status, and timing.
• Omega-3 fatty acids may modulate immune responses and reduce inflammation and anemia, but evidence is limited.
• Individualized assessment of nutrient status and cautious interpretation of supplementation benefits are crucial.

Conclusions:

• Current evidence does not support routine iron or omega-3 fatty acid supplementation in tuberculosis.
• Further research is needed to establish clear clinical recommendations for individualized nutritional interventions.
• Optimal timing, safety, and efficacy of these supplements require more investigation.